Skip to main content

Dalrada Corporation expands technology division with acquisition of Deposition Technology ltd.

By April 7, 2022November 6th, 2022No Comments

For semiconductor, micro-electromechanical systems (MEMS), and medical and optoelectronics device manufacturers, DepTec manufactures chemical vapor and physical vapor deposition systems. The company also designs, develops, manufactures, and services advanced vacuum and plasma technology-based systems as well as control systems and software solutions for the semiconductor industry.

Rob MacKenzie, Director and Co-Founder of DepTec says, “We are extremely proud to become part of the Dalrada group of companies and are confident that this provides DepTec a platform to expand our market penetration and portfolio expansion at an accelerated pace. DepTec is ideally positioned to collaborate with Likido® Green Energy products and will assist in developing semiconductor manufacturing channels.”

MacKenzie added, “We are also pleased to continue assisting customers with advancing their corporate environmental responsibility and ESG goals by reducing equipment carbon footprints and reducing power, gas, and chemical consumption, in conjunction with Likido®.”

Dalrada continuously creates innovative, impactful solutions to address the complex challenges of today and the future. To learn more about Dalrada Corporation, please visit

About Dalrada (DFCO)

With perseverance, valor, dedication, and vision, Dalrada Corporation is dedicated to tackling worldwide challenges of today and tomorrow.

Dalrada is a global company that operates under the tenet of creating impactful innovations that matter for the world. The Company works continually to produce disruptive solutions that bridge the gap of accessibility and accelerate positive change for current and future generations.

Established in 1982, the Company has since grown its footprint to include the business divisions: Dalrada Health, Dalrada Precision, and Dalrada Technologies. Each of Dalrada’s subsidiaries actively produces affordable and accessible world-class solutions to global problems. For more information, please visit

About Deposition Technology Ltd. (DepTec)

DepTec was founded in 2004 to provide refurbished Varian PVD Systems, including the 3180/3190, 3290 and XM-90 systems as well as the Novellus Concept 1 and 2 PECVD Systems.

Over the years, the company has developed re-manufacturing capabilities and robust upgrades to legacy systems to keep them in operation while updating them with the latest technology and advanced features.

In 2014, DepTec developed its own unique PVD system, the EVOS, and entered the OEM arena. The company now has multiple systems installed to assist in producing devices used in the latest medical and communications products.

DepTec innovates with continuous R&D programs, developing the next generation of precision equipment and upgrades. To learn more about Deposition Technology Ltd., please visit


Statements in this press release that are not historical facts, the statements are forward-looking, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management’s current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to several important factors and will be dependent upon a variety of factors including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations regarding these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the US Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K.

# # #

Skip to content